Dangerous Trial in Fetal Engineering?
A new report reveals the details of a troubling off-label medical intervention used in the U.S. to alter the development of unborn children for sex normalization purposes. The pregnant women targeted are at risk for having a child born with congenital adrenal hyperplasia (CAH), an endocrinological condition that may result in female fetuses being born with intersex or more male-typical genitals and brains, according to a Northwestern University press release . Some of these women are given a synthetic steroid